Medicare Enrolled

Dr. Douglas Stuart, M.D.

Neurology · Atlanta, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
3200 DOWNWOOD CIR NW, Atlanta, GA 30327
4043510205
In practice since 2005 (20 years)
NPI: 1548251572 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Stuart from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Stuart? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Stuart

Dr. Douglas Stuart is a neurology specialist in Atlanta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Stuart performed 1,392 Medicare services across 1,035 unique beneficiaries.

Between the years covered by Open Payments, Dr. Stuart received a total of $599,227 from 53 pharmaceutical and/or device companies across 1164 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Stuart is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 23% volume in GA $599,227 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,392
Medicare services
Top 23% in GA for neurology
1,035
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~70 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
579 $90 $137
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
354 $60 $95
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
87 $129 $189
MRI scan of brain, without contrast
A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves.
81 $144 $257
New patient office visit, complex (60-74 min) 60 $155 $228
MRI of upper spine without contrast
An MRI scan of the upper spinal canal that does not use contrast dye. This imaging test uses magnetic fields and radio waves to create detailed pictures of the spine.
43 $101 $298
Limited needle EMG of arm or leg muscles
A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area.
37 $47 $66
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
37 $76 $104
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
33 $57 $168
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
21 $82 $241
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
17 $94 $319
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
17 $125 $467
Psychological test administration, first 30 minutes
A technician administers psychological or neuropsychological testing for the first 30 minutes.
15 $25 $39
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
11 $97 $160
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$599,227
Total received (2018-2024)
Avg $85,604/year across 7 years
Top 1% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
1,164
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$549,863 (91.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$39,752 (6.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,613 (1.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$47,801
2023
$82,914
2022
$78,547
2021
$48,388
2020
$24,182
2019
$150,657
2018
$166,738

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
TG Therapeutics, Inc.
$32,206
E.R. Squibb & Sons, L.L.C.
$5,791
Biogen, Inc.
$4,129
Celgene Corporation
$2,919
EMD Serono, Inc.
$558
ABBVIE INC.
$333
Eisai Inc.
$289
Alexion Pharmaceuticals, Inc.
$253
Novartis Pharmaceuticals Corporation
$213
ARGENX US, INC.
$168
UCB, Inc.
$147
Lilly USA, LLC
$119
Amgen Inc.
$93
MDD US Operations, LLC
$92
Neurocrine Biosciences, Inc.
$76
ACADIA Pharmaceuticals Inc
$56
Lundbeck LLC
$43
BANNER LIFE SCIENCES, LLC
$43
Merz Pharmaceuticals, LLC
$38
Teva Pharmaceuticals USA, Inc.
$36
Genentech USA, Inc.
$36
PFIZER INC.
$33
Alnylam Pharmaceuticals Inc.
$28
Mallinckrodt Hospital Products Inc.
$25
Axsome Therapeutics, Inc.
$22
Cycle Pharmaceuticals Inc
$21
CATALYST PHARMACEUTICALS, INC.
$20
Kyowa Kirin, Inc.
$13
Top 3 companies account for 88.1% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$207,726
E.R. Squibb & Sons, L.L.C.
$82,080
Novartis Pharmaceuticals Corporation
$77,201
Celgene Corporation
$52,514
TG THERAPEUTICS, INC.
$42,043
Genentech USA, Inc.
$42,014
GENZYME CORPORATION
$34,926
TG Therapeutics, Inc.
$32,206
EMD Serono, Inc.
$11,591
Alexion Pharmaceuticals, Inc.
$8,260
Horizon Therapeutics plc
$3,730
ABBVIE INC.
$408
Amgen Inc.
$398
UCB, Inc.
$369
AbbVie Inc.
$367
Eisai Inc.
$311
Neurocrine Biosciences, Inc.
$304
ACADIA Pharmaceuticals Inc
$279
Teva Pharmaceuticals USA, Inc.
$265
Lilly USA, LLC
$228
ARGENX US, INC.
$219
SK Life Science, Inc.
$157
PFIZER INC.
$147
HARMONY BIOSCIENCES LLC
$115
Arbor Pharmaceuticals, Inc.
$100
BANNER LIFE SCIENCES, LLC
$97
Acorda Therapeutics, Inc
$92
MDD US Operations, LLC
$92
IMPEL PHARMACEUTICALS INC.
$90
Lundbeck LLC
$88
Merz Pharmaceuticals, LLC
$87
BOSTON SCIENTIFIC CORPORATION
$83
Mallinckrodt Hospital Products Inc.
$79
Neurelis, Inc.
$65
Supernus Pharmaceuticals, Inc.
$49
Amneal Pharmaceuticals LLC
$46
Harmony Biosciences LLC
$40
Axsome Therapeutics, Inc.
$38
IDORSIA PHARMACEUTICALS US INC
$37
Otsuka America Pharmaceutical, Inc.
$35
Kyowa Kirin, Inc.
$28
Alnylam Pharmaceuticals Inc.
$28
SANOFI-AVENTIS U.S. LLC
$24
EISAI INC.
$23
Cycle Pharmaceuticals Inc
$21
CATALYST PHARMACEUTICALS, INC.
$20
Marinus Pharmaceuticals, Inc.
$20
JAZZ PHARMACEUTICALS INC.
$20
AstraZeneca Pharmaceuticals LP
$19
Greenwich Biosciences, Inc.
$14
ARBOR PHARMACEUTICALS, INC.
$13
Banner Life Sciences, LLC
$12
Impax Laboratories, Inc.
$12
Top 3 companies account for 61.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Briviact · COMIRNATY · EMGALITY · EPIDIOLEX · Epidiolex · FLUMIST QUADRIVALENT · FYCOMPA · Fycompa · GILENYA · General - Pain Management · Gocovri · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MS DISEASE STATE · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · Ocrevus · Ocrevus Zunovo · Ongentys · Ozanimod · PANZYGA · PAXLOVID · PIPELINE-MS · QULIPTA · QUVIVIQ · REXULTI · RYTARY · Rebif · Rystiggo · SKYCLARYS · SOLIRIS · Soliris · Sunosi · TECFIDERA · TEFLARO · TROKENDI XR · TYSABRI · Tascenso ODT · Trudhesa · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · WAKIX · Wakix · XCOPRI · Xeomin · ZEPOSIA · ZTALMY · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in GA.

Looking for a neurology specialist in Atlanta?
Compare neurologists in the Atlanta area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
230
Per 100K population
21.5
County median income
$91,490
Nearest hospital
SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC
2.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Stuart is a clinical cardiology specialist, with above-average Medicare volume (top 23% in GA), with speaking/promotional industry engagement in the top 1% of GA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Stuart experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Stuart performed 579 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Stuart receive payments from pharmaceutical companies?
Yes. Dr. Stuart received a total of $599,227 from 53 companies across 1,164 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Stuart's costs compare to other neurologists in Atlanta?
Dr. Stuart's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Stuart) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →